During the past decade, Emory Proton Therapy Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emory Proton Therapy Center" #1 sponsor was "NRG Oncology" with 7 trials, followed by "Emory University" with 4 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emory Proton Therapy Center" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "European Organisation for Research and Treatment Center (EORTC)" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Emory Proton Therapy Center" are "Clinical Stage II Esophageal Adenocarcinoma AJCC v8" (2 trials), "Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8" (2 trials), "Clinical Stage III Esophageal Adenocarcinoma AJCC v8" (2 trials), "Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8" (2 trials) and "Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8" (2 trials). Many other conditions were trialed in "Emory Proton Therapy Center" in a lesser frequency.

Most popular intervention types in "Emory Proton Therapy Center" are "Radiation" (15 trials), "Drug" (12 trials), "Procedure" (7 trials), "Other" (6 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (4 trials), "Intensity-Modulated Radiation Therapy" (4 trials), "Radiation Therapy" (4 trials), "Cisplatin" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Emory Proton Therapy Center" are 16 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Emory Proton Therapy Center". undefined are not yet recruiting, 14 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Emory Proton Therapy Center, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Emory Proton Therapy Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".